Dame Emma Natasha Walmsley DBE (born June 1969) is the chief executive officer (CEO) of GSK plc. [1] She succeeded Sir Andrew Witty, who retired in March 2017. [2] Before GSK, she …

(Courtesy GSK) GlaxoSmithKline appointed Emma Walmsley, the head of its consumer business, to become its next chief executive. She is the first woman to run a major pharmaceutical giant....

Apr 21, 2023 · Headlining exciting innovation in the pharmaceutical world, Dame Emma Walmsley has been the CEO of GSK since 2017, making her the first woman to run a major …

Jan 23, 2021 · On 1 st April 2017, the GSK Board of Directors made the decision to appoint Emma Walmsley as the first female CEO in the 300-year history of GSK. By many key …

3 days ago · For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it revealed (PDF) that Walmsley took a 16% pay cut in 2024, it …

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off …

Emma Walmsley, CEO of GSK, is nearly eight years into her effort to return the British pharma company to growth, and her work is starting to pay off. Much credit goes to Arexvy, GSK’s...

Dame Emma Walmsley | Chief Executive Officer Emma joined the Board as CEO Designate on 1 January 2017 and became CEO on 1 April 2017. She has been a member of the GSK …

May 21, 2024 · A vaccine breakthrough helped Walmsley keep her job after Elliot's argued in 2021 that Britain’s oldest drugmaker had “lost its way.”